Forbes lifts marketing capabilities in US
Canada's Forbes Medi-Tech is hoping that a new distribution deal coupled with new findings on the benefits of lowering cholesterol will boost sales of its key product Reducol.
Canada's Forbes Medi-Tech is hoping that a new distribution deal coupled with new findings on the benefits of lowering cholesterol will boost sales of its key product Reducol.
Australia's medicines regulator has published draft guidelines for the registration of complementary medicines, which are also expected to form the basis of rules under the controversial joint agency with New Zealand.
A diet rich in vitamin E appears to protect against both prostate cancer and bladder cancer, according to new research that lifts hopes for the vitamin after disappointing recent studies, writes Dominique Patton.
Taking a folic acid supplement may stop the onset of migraines, says an Australasian team, which has discovered a gene that is linked to the most severe and debilitating form of headache, migraine with aura.
A simple blood test could determine whether older women with diabetes would benefit from or be at risk from vitamin doses designed to protect their ailing hearts, according to researchers at the Technion-Israel Institute of Technology.
Hansen Natural, the company that last week launched a new energy drink onto the market reports a leap in income for the year on the back of strong sales in its Monster Energy brand. While soy-based food product firm Tofutti weathers a stormy moment.
Hopping on board the fast-moving low carb train, Arla Food Ingredients, the supplier of tooth-friendly sweetener tagatose, says a new study from Australian scientists confirms the product's low glycaemic response.